HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 186 filers reported holding HERON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $52,016 | -28.2% | 34,448 | +18.9% | 0.00% | -100.0% |
| Q4 2022 | $72,403 | -46.4% | 28,961 | -10.1% | 0.00% | 0.0% |
| Q3 2022 | $135,000 | +75.3% | 32,232 | +16.4% | 0.00% | 0.0% |
| Q2 2022 | $77,000 | -48.7% | 27,680 | +5.7% | 0.00% | 0.0% |
| Q1 2022 | $150,000 | -37.0% | 26,177 | +0.5% | 0.00% | -50.0% |
| Q4 2021 | $238,000 | -15.6% | 26,057 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $282,000 | -23.0% | 26,351 | +11.6% | 0.00% | -33.3% |
| Q2 2021 | $366,000 | -10.1% | 23,602 | -6.1% | 0.00% | -25.0% |
| Q1 2021 | $407,000 | -23.2% | 25,126 | +0.4% | 0.00% | -20.0% |
| Q4 2020 | $530,000 | +37.7% | 25,031 | -3.7% | 0.01% | +25.0% |
| Q3 2020 | $385,000 | +35.6% | 25,982 | +34.6% | 0.00% | 0.0% |
| Q2 2020 | $284,000 | +20.3% | 19,309 | -3.9% | 0.00% | 0.0% |
| Q1 2020 | $236,000 | – | 20,084 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |